Mosaic ImmunoEngineering, Inc. (CPMV)
OTCMKTS · Delayed Price · Currency is USD
0.5000
-0.0630 (-11.19%)
Mar 18, 2026, 3:50 PM EST
Mosaic ImmunoEngineering Market Cap
Mosaic ImmunoEngineering has a market cap or net worth of $3.62 million as of March 19, 2026. Its market cap has decreased by -9.09% in one year.
Market Cap
3.62M
Enterprise Value
5.24M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.50
Market Cap Chart
Since October 15, 2020, Mosaic ImmunoEngineering's market cap has increased from 1.69M to 3.62M, an increase of 114.79%. That is a compound annual growth rate of 15.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 16, 2026 | 4.08M | 81.03% |
| Dec 31, 2025 | 2.25M | -55.65% |
| Dec 31, 2024 | 5.08M | 16.87% |
| Dec 29, 2023 | 4.35M | -39.39% |
| Dec 30, 2022 | 7.17M | -2.75% |
| Dec 31, 2021 | 7.37M | 181.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AccuStem Sciences | 6.04M |
| Nymox Pharmaceutical | 5.62M |
| GPL Holdings | 4.17M |
| Enzon Pharmaceuticals | 3.71M |
| Galera Therapeutics | 3.64M |
| Burzynski Research Institute | 3.29M |
| Clearside Biomedical | 3.23M |
| Bioxytran | 3.17M |